Naima Nur | Microbiology | Best Researcher Award

Published on by Global Diseases Research

Best Researcher Award

Naima Nur
Management Scientice for Health, Bangladesh

Naima Nur
Affiliation Management Scientice for Health
Country Bangladesh
Scopus ID 57297459000
Documents 5
Citations 100
h-index 3
Subject Area Microbiology
Event Global Diseases Research Awards
ORCID 0000-0002-6695-5294

Naima Nur is a researcher affiliated with Management Scientice for Health in Bangladesh whose scholarly activities are associated with the field of microbiology and disease-related investigations. Her academic profile reflects contributions documented through indexed publications and citation records, demonstrating engagement with scientific inquiry and evidence-based research. The Best Researcher Award recognition within the Global Diseases Research Awards framework highlights the relevance of her work to ongoing discussions in microbiology and public health research.[1]

Abstract

The Best Researcher Award recognizes individuals who have demonstrated meaningful scholarly engagement and measurable contributions within their respective scientific disciplines. Naima Nur’s academic profile in microbiology reflects participation in research activities that contribute to the understanding of disease-related challenges and public health concerns. Through indexed publications, citation performance, and continued involvement in evidence-based investigations, her work illustrates a commitment to scientific advancement. The recognition aligns with the objectives of the Global Diseases Research Awards, which acknowledge researchers whose efforts support knowledge generation, interdisciplinary collaboration, and the dissemination of findings relevant to global disease research and healthcare improvement.[1][2]

Keywords

Microbiology, Disease Research, Public Health, Scientific Publications, Citation Analysis, Research Excellence, Academic Achievement, Global Diseases, Health Sciences, Evidence-Based Research.

Introduction

Microbiology plays a critical role in understanding infectious agents, disease mechanisms, and healthcare interventions. Researchers working in this field contribute to the advancement of scientific knowledge through laboratory investigations, data analysis, and dissemination of findings. Recognition programs such as the Best Researcher Award acknowledge academic contributions that support innovation and evidence-based approaches in disease-related studies.[2]

Research Profile

Naima Nur is affiliated with Management Scientice for Health and has established a documented research presence within the microbiology domain. Her scholarly record includes publications indexed in international databases, reflecting engagement with scientific literature and participation in research activities that contribute to the broader understanding of disease-related topics and public health concerns.[1]

Research Contributions

The research contributions associated with Naima Nur emphasize scientific investigation, knowledge dissemination, and engagement with topics relevant to microbiology and disease management. Her work contributes to the accumulation of evidence that informs healthcare practices and supports ongoing efforts to address challenges associated with infectious diseases and related public health issues.[1]

Publications

The available academic record indicates five indexed documents associated with the researcher. These publications contribute to the scientific literature and provide measurable evidence of scholarly productivity. Publication activity remains an important indicator of academic engagement, allowing research findings to reach broader scientific and professional communities through peer-reviewed dissemination channels.[1]

Research Impact

Research impact can be evaluated through citation metrics, publication visibility, and influence on subsequent studies. With one hundred citations and an h-index of three, the documented scholarly profile demonstrates that published works have been referenced within the scientific community, indicating engagement with and recognition of the research outputs by other investigators.[1]

Award Suitability

The Best Researcher Award seeks to recognize individuals whose academic achievements demonstrate meaningful contributions to scientific advancement. Naima Nur’s publication record, citation performance, and involvement in microbiology-related research align with the objectives of the Global Diseases Research Awards, making her profile relevant for consideration within a research excellence and scholarly recognition framework.[1][2]

Conclusion

Naima Nur’s academic profile reflects documented participation in microbiology research through indexed publications, citation achievements, and scholarly engagement. Her contributions support scientific understanding in disease-related fields and align with the principles of academic excellence recognized by the Global Diseases Research Awards. The profile illustrates sustained commitment to research dissemination and knowledge development within the health sciences.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Naima Nur, Author ID 57297459000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57297459000
  2. Global Diseases Research Awards. (n.d.). Best Researcher Award and Academic Recognition Programs.
    https://globaldiseases.org/
  3. Nur, N., Sharif, A. B., Khan, A., Islam, M. R., Soualhine, H., Nasreen, Z., Khan, A. H., Modak, P. K., Alam, M. F., Islam, S., Islam, S., Khan, N., & Sharma, M. K. (2026). Patterns of multidrug resistance and treatment outcomes among pulmonary tuberculosis patients in Bangladesh. Pathogens, 15(2), 208.
    https://doi.org/10.3390/pathogens15020208
  4. Hawlader, M. D. H., Rashid, M. U., Khan, M. A. S., et al. (2023). Quality of life of COVID-19 recovered patients: A 1-year follow-up study from Bangladesh. Infectious Diseases of Poverty, 12(1), 79.
    https://doi.org/10.1186/s40249-023-01125-9
  5. Nur, N., Sharif, A. B., & Mitra, D. K. (2023). Stress resilience in patients with drug-resistant tuberculosis. The International Journal of Tuberculosis and Lung Disease, 27(7), 551–556.
    https://doi.org/10.5588/ijtld.22.0648

 

“`

Raeesa Manjoo-Docrat | Infectious Diseases | Young Researcher Award

Published on by Global Diseases Research

Dr. Raeesa Manjoo-Docrat | Infectious Diseases | Young Researcher Award 

Lecturer | Univeristy of the Witwatersrand | South Africa

Dr. Raeesa Manjoo-Docrat is a developing scholar affiliated with the University of the Witwatersrand, Johannesburg, whose work contributes to the advancement of quantitative epidemiology and public health modelling in South Africa. Her research focuses on the development and application of spatial, age-stratified epidemiological models aimed at understanding disease transmission dynamics within heterogeneous populations. With four peer-reviewed publications and 27 citations, she has established a growing academic footprint supported by an h-index of 2, reflecting the early but significant influence of her work. Her recent open-access article in Heliyon (2025), which applies spatial modelling frameworks to the South African COVID-19 pandemic, exemplifies her commitment to integrating mathematical rigor with real-world public health challenges. Manjoo-Docrat has collaborated with multidisciplinary teams comprising epidemiologists, mathematicians, and public health scientists, enabling her to contribute to robust analytical frameworks and high-quality scientific outputs. These collaborations also highlight her ability to operate effectively within diverse research environments and to engage in evidence-based problem solving that supports both academic and policy-relevant outcomes. Her research sits at the intersection of infectious disease dynamics, health systems planning, and data-driven decision support, positioning her work within a globally relevant domain of applied epidemiology. Beyond academic metrics, her contributions have societal impact by informing approaches to epidemic preparedne  ss, guiding interventions for vulnerable demographic groups, and enhancing understanding of spatial disparities in health outcomes. Through her continued scholarship, Manjoo-Docrat aims to strengthen the integration of mathematical modelling into national and regional public health strategies, ensuring that data-informed insights contribute to improved health resilience and equitable disease control.

Profiles: Scopus | ORCID

Featured Publications

1. Manjoo-Docrat, R., Abdelatif, N., Holloway, J., Dudeni-Tlhone, N., Dresselhaus, C., Mbayise, E., … Makhanya, S. (2025). Spatial age-stratified epidemiological model with applications to South African COVID-19 pandemic. Heliyon, 11(11), e43171. https://doi.org/10.1016/j.heliyon.2025.e43171

2. Dresselhaus, C., Fabris-Rotelli, I., Manjoo-Docrat, R., Brettenny, W., Holloway, J., Thiede, R., Debba, P., & Dudeni-Tlhone, N. (2023). A spatial model with vaccinations for COVID-19 in South Africa. Spatial Statistics, 58, Article 100792. Cited by 2.

3. Manjoo-Docrat, R. (2022). A spatio-stochastic model for the spread of infectious diseases. Journal of Theoretical Biology, 533, 110943.  Cited by 16.

4. Fabris-Rotelli, I., Holloway, J., Kimmie, Z., Archibald, S., Debba, P., Manjoo-Docrat, R., … Potgieter, A. (2022). A Spatial SEIR Model for COVID-19 in South Africa. Journal of Data Science, Statistics, and Visualisation, 2(7), 14–45.  Cited by 5.

Ragala Venkata Nandha | Clinical Microbiology | Best Scholar Award

Published on by Global Diseases Research

Mr. Ragala Venkata Nandha | Clinical Microbiology | Best Scholar Award 

Research Scholar at University of Madras, India

Ragala Venkata Nandha is a passionate young researcher currently pursuing his PhD in Medical Microbiology at Dr. ALM PG Institute of Basic Medical Sciences, University of Madras, Chennai. With a strong foundation in microbiological sciences, his work centers on antimicrobial resistance and advanced diagnostic techniques. He holds a Master’s degree in Medical Microbiology and a Bachelor’s in Medical Laboratory Technology. Nandha has contributed to multiple research projects funded by CMRG and RUSA 2.0, addressing clinical microbiology and drug resistance mechanisms. His scientific publications and conference presentations underscore his active engagement in cutting-edge research. As a first and co-author, he has contributed to reputed international journals and book chapters. He is a contributing member of the American Society for Microbiology and actively participates in conferences and workshops. Known for his practical expertise in molecular biology and microbial diagnostics, Nandha is committed to advancing solutions for combating infectious diseases and public health threats.

Professional Profiles

Scopus

Education

Ragala Venkata Nandha is academically trained in the field of microbiology and medical laboratory technology. He is currently enrolled in a PhD program in Medical Microbiology at the Department of Microbiology, Dr. ALM PG IBMS, University of Madras, where he is investigating antimicrobial resistance mechanisms. Prior to his doctoral studies, he earned his Master of Science (M.Sc.) in Medical Microbiology from the same institute, where he conducted research on probiotic enhancement. His undergraduate studies were in Medical Laboratory Technology (B.Sc. MLT) at Dr. NTR University, Vijayawada, Andhra Pradesh. Throughout his academic journey, Nandha has consistently focused on clinical microbiology, diagnostics, and molecular biology. His education has provided him with solid theoretical grounding and extensive hands-on laboratory experience in handling clinical specimens, performing molecular diagnostics, and applying modern research methodologies to real-world medical problems. His academic foundation supports his current research in combating multidrug-resistant pathogens.

Experience

Ragala Venkata Nandha has gained practical and research experience through his roles as a Project Fellow in two major funded research projects. He is currently working as a CMRG Project Fellow in the Department of Genetics at Dr. ALM PG IBMS, University of Madras, where he is developing a multiplex LAMP assay for rapid detection of resistance genes in colistin-resistant Enterobacteriaceae. Prior to this, he served as a RUSA 2.0 Project Fellow, focusing on the neuroimmunoendocrine effects of natural resources in neurodegenerative diseases. His experience includes microbial culture, molecular techniques such as PCR and sequencing, antimicrobial susceptibility testing, and analysis of co-resistance patterns. He also has hands-on training in animal handling and diagnostic laboratory workflows. These roles have enhanced his understanding of translational research and enabled him to contribute significantly to microbiology and infectious disease research at the institutional and national levels.

Research Focus 

Ragala Venkata Nandha’s research is centered on antimicrobial resistance (AMR) and molecular diagnostics. His current PhD project involves the isolation and molecular profiling of carbapenem- and colistin-resistant Gram-negative bacteria from clinical samples. The research aims to understand co-resistance patterns and the evolutionary mechanisms underlying these pathogens. In the CMRG project, he is developing a multiplex LAMP assay to detect mcr-1 to mcr-9 genes responsible for colistin resistance. His postgraduate work explored the prebiotic potential of spinach on probiotic growth, contributing to the understanding of gut microbiota modulation. He has also studied nanotechnology-based antimicrobial agents like eco-friendly silver nanoparticles. His work integrates microbiology, molecular biology, and bioinformatics to address critical healthcare challenges. With expertise in techniques like real-time PCR, Sanger sequencing, and bioinformatics analysis, his goal is to innovate diagnostics and therapeutic strategies for combating drug-resistant infections and improving clinical outcomes.

Publication Top Notes

Title: Advancing beyond conventional vaccines: The potential of next-generation vaccines in combatting antibiotic-resistant bacteria

Journal: Indian Journal of Medical Microbiology

Summary

This article explores the emerging landscape of next-generation vaccines designed to address the growing threat of antibiotic-resistant bacteria. Unlike traditional vaccines, which primarily rely on attenuated or inactivated pathogens, next-gen vaccines leverage novel platforms such as mRNA, recombinant proteins, vector-based systems, and nanoparticle technologies. The paper highlights how these vaccines offer greater specificity, faster development timelines, and adaptability against evolving bacterial strains. It also examines clinical trials, current research trends, and regulatory challenges, emphasizing the crucial role these vaccines play in reducing reliance on antibiotics and slowing antimicrobial resistance (AMR) worldwide.

Conclusion

Ragala Venkata Nandha represents a new generation of focused, skilled, and research-driven microbiologists working at the intersection of clinical diagnostics and antimicrobial resistance. His academic foundation, complemented by ongoing doctoral research, showcases a strong commitment to scientific inquiry and innovation. From molecular biology and nanotechnology to clinical microbiology and bioinformatics, his multidisciplinary approach addresses urgent public health concerns. His contributions as a project fellow, author, and conference presenter reflect both technical expertise and scientific maturity. As a member of international scientific communities and contributor to peer-reviewed literature, he continues to build a credible research profile. With promising achievements in diagnostics development and microbial resistance studies, Nandha is well-positioned to make a lasting impact in translational microbiological research. His journey reflects a dedication not only to academic excellence but also to solving real-world health challenges through research, collaboration, and innovation. He is a valuable asset to the scientific and medical research community.